The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). (Q34374016)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). |
scientific article |
Statements
1 reference
The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). (English)
1 reference
Lars Wallentin
1 reference
John W Eikelboom
1 reference
Salim Yusuf
1 reference
Michael D Ezekowitz
1 reference
Paul A Reilly
1 reference
Thorsten Lehr
1 reference
Sebastian Haertter
1 reference
Gerhard Nehmiz
1 reference
Stuart J Connolly
1 reference
Susan Wang
1 reference
RE-LY Investigators
1 reference
27 September 2013
1 reference
1 reference
Identifiers
1 reference